替西罗莫司 - CAS:162635-04-3 - 研锐化学-溶剂、试剂、原料、耗材、仪器、[研化商城]

替西罗莫司

英文名： Temsirolimus 别名：西罗莫司脂化物;替西罗莫司;1,1-二氯-1-氟乙烷;Temsirolimus 抑制剂;坦西莫司;西罗莫司;西罗莫司脂化物 Temsirolimus;西罗莫司脂化物标准品;西罗莫司酯化物;雷帕霉素;坦罗莫司;雷帕霉素42-[3-羟基-2-(羟甲基)-2-甲基丙酸酯];替西莫司;替西罗莫;坦西莫司(替西罗莫司);坦罗莫司(替西罗莫司);坦西莫司, 西罗莫司脂化物

商品编号：R023417-25mg 规格：25mg 纯度：95%

CAS号： 162635-04-3 分子式：C56H87NO16 分子量：1030.29

价格	¥ 4480.00 （请登录会员查看折扣价）
货期	5~7个工作日

数量

中文名称：	替西罗莫司
中文别名：	西罗莫司脂化物;替西罗莫司;1,1-二氯-1-氟乙烷;Temsirolimus 抑制剂;坦西莫司;西罗莫司;西罗莫司脂化物 Temsirolimus;西罗莫司脂化物标准品;西罗莫司酯化物;雷帕霉素;坦罗莫司;雷帕霉素42-[3-羟基-2-(羟甲基)-2-甲基丙酸酯];替西莫司;替西罗莫;坦西莫司(替西罗莫司);坦罗莫司(替西罗莫司);坦西莫司, 西罗莫司脂化物
smiles：	O(C([H])([H])[H])[C@@]1([H])[C@@]([H])(C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[C@@]([H])(C([H])([H])[H])[C@]2([H])C([H])([H])C([C@@]([H])(C([H])=C(C([H])([H])[H])[C@]([H])([C@]([H])(C([C@]([H])(C([H])([H])[H])C([H])([H])[C@]([H])(C([H])([H])[H])C([H])=C([H])C([H])=C([H])C([H])=C(C([H])([H])[H])[C@]([H])(C([H])([H])[C@]3([H])C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])[C@@](C(C(N4C([H])([H])C([H])([H])C([H])([H])C([H])([H])[C@@]4([H])C(=O)O2)=O)=O)(O[H])O3)OC([H])([H])[H])=O)OC([H])([H])[H])O[H])C([H])([H])[H])=O)C1([H])[H])OC(C(C([H])([H])[H])(C([H])([H])O[H])C([H])([H])O[H])=O \|c:35,66,70,t:62\|
英文名称：	Temsirolimus
英文别名：	Temsirolimus;Temsirolimus (CCI-779, NSC 683864);42-[3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate]Rapamycin;Temsirolimus (cell cycle inhibitor 779,CCI-779,Torisel®);[14C]-Temsirolimus;CCI779;CCL-779;Rapamycin (42-[3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate];rapaMycin 42-ester with 3-hydroxy-2-(hydroxyMethyl)-2-Methylpropionic acid;TeMsiroliMus (~);TeMsiroliMus (CCI-779,Torisel);TeMsiroliMus (Torisel);CCI-779;Rapamycin 42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate];C15182;NSC 683864;Temsirolimus(CCI-779);Torisel;624KN6GM2T;42-[3-Hydroxy-2-methylpropanoate;Cci 779;Temserolimus;Temsirolimus - Torisel;Rapamycin 42-(2,2-bis(hydroxymethyl)propionate);DSSTox_CID_20945;DSSTox_RID_79605;DSSTox_GSID_40945;42-(3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate)rapamycin;Rapamycin 42-[3-hydroxy-2-(hydroxym;Rapamycin 42-ester with 2,2-bis-(hydroxymethyl)propionic acid;GTPL5892;Temsirolimus (>80%);Rapamycin 42-;CHEBI:79699;L01XE09;CHEMBL1201182;TEMSIROLIMUS [WHO-DD];BRD-K08177763-001-02-6;DTXCID0020945;TEMSIROLIMUS [INN];TEMSIROLIMUS [ORANGE BOOK];NCGC00167518-09;WAY-CCI 779;AKOS025142069;SR-01000898799-3;s1044;Q7699074;NSC-683864;CCG-264790;TEMSIROLIMUS [JAN];T3574;J-009958;MFCD00934421;Temsirolimus [USAN:INN:BAN:JAN];TEMSIROLIMUS [EMA EPAR];TEMSIROLIMUS (MART.);CBPNZQVSJQDFBE-FUXHJELOSA-N;Tox21_112515;AM84554;SCHEMBL18792;NCGC00167518-01;AB01274736-01;162635-04-3;TEMSIROLIMUS [MI];NCGC00167518-02;SR-01000898799;Temsirolimus [USAN];TEMSIROLIMUS [MART.];UNII-624KN6GM2T;Rapamycin, 42-(3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate);Rapamycin 42-[3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate];Temsirolimus, >=98% (HPLC);BDBM50343413;CAS-162635-04-3;HY-50910;(1R,2R,4S)-4-{(2R)-2-[(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,30S,34aS)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontin-3-yl]propyl}-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate;A4I;DTXSID2040945;TEMSIROLIMUS [VANDF];CS-0129;NCGC00167518-05;42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate]-rapamycin;HSDB 7931;AB01274736_02;temsirolimusum
CAS号：	162635-04-3
分子式：	C56H87NO16
分子量：	1030.29
密度：
熔点：
沸点：
闪点：
水溶性：
蒸气压：

搜索质检报告(COA)

搜索MSDS